Concepedia

Hideo Hirai

HH

Statistics

Publications

21

Citations

743

H-Index

17

Active since

1985

Affiliations

Pfizer (United States)(Current)

Pfizer (Japan)

Meijo University

Hiroshima Cosmopolitan University

University of Cambridge

Hideo Hirai is an author at Pfizer (United States) specializing in life sciences, mycology, and drug discovery.

Publications per year

1985–2021

21

Publications

21

A New Antibiotic CJ-17,665 from Aspergillus ochraceus.

Yutaka Sugie, Hideo Hirai, TAISUKE INAGAKI et al. · The Journal of Antibiotics · 2001 · 100 citations · Full text

, , +6

Erinacine E as a Kappa Opioid Receptor Agonist and Its New Analogs from a Basidiomycete, Hericium ramosum.

Toshiyuki Saito, FUKUMATSU AOKI, Hideo Hirai et al. · The Journal of Antibiotics · 1998 · 74 citations · Full text

, , +10

CJ-15,208, a Novel Kappa Opioid Receptor Antagonist from a Fungus, Ctenomyces serratus ATCC15502.

Toshiyuki Saito, Hideo Hirai, Yoon-Jeong Kim et al. · The Journal of Antibiotics · 2002 · 66 citations · Full text

, , +10

CJ-12,371 and CJ-12,372, Two Novel DNA Gyrase Inhibitors. Fermentation, Isolation, Structural Elucidation and Biological Activities.

Shinichi Sakemi, TAISUKE INAGAKI, KEIJI KANEDA et al. · The Journal of Antibiotics · 1995 · 59 citations · Full text

, , +6

Novel Lactone Compounds from Mortierella verticillata that Induce the Human Low Density Lipoprotein Receptor Gene: Fermentation, Isolation, Structural Elucidation and Biological Activities.

Koen Dekker, Robert J. Aiello, Hideo Hirai et al. · The Journal of Antibiotics · 1998 · 55 citations · Full text

, , +8

1–5 of 21